# Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient

> **NCT05033548** · — · TERMINATED · sponsor: **CareDx** · enrollment: 246 (actual)

## Conditions studied

- Transplant

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05033548
- **Lead sponsor:** CareDx
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-10-26
- **Primary completion:** 2023-02-02
- **Final completion:** 2023-07-31
- **Target enrollment:** 246 (ACTUAL)
- **Why stopped:** Decision by Sponsor after careful review of study data available.
- **Last updated:** 2023-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05033548

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05033548, "Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05033548. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*